• Indian Pharma Industry..
    The first Indian pharmaceutical company, Bengal Chemicals and Pharmaceutical Works, which still exists today as one of 5 government-owned drug manufacturers, appeared in Calcutta in 1930. For the next 60 years, most of the drugs in India were imported by multinationals either in fully-formulated or
    Premium 4197 Words 17 Pages
  • Indian Pharma
    ACKNOWLEDGEMENT We would like to express our heartfelt gratitude and thankfulness towards our Industry Analytics professors, Dr. R.Venkatamuni Reddy and Dr. Gervasio S.F.L Mendes for giving us an opportunity to work on this project, which has helped us gain an in depth understanding of the Indian
    Premium 25636 Words 103 Pages
  • Ranbaxy Journey.. so Far
    Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the g
    Premium 5106 Words 21 Pages
  • Boom in Pharma and Health Care Sector
    A project report on “Boom In Pharma And Health Care Sector ” In partial fulfillment of Master of Business Administration 2007-09 [pic] Department of Management Studies Jai Narain Vyas University, Jodhpur Submitted to: Submitted by: Khandwala Integ
    Premium 11049 Words 45 Pages
  • Indian Pharma Industry
    Management 360-Term Paper Submitted to: Mr. Arvind Gandhi Submitted By: 1. C.V.V.Veda Vyas (10207) 2. K.Chaitanya (10208) 3. Siva.Chebrolu (10209) 4. K.Deepak (10210) 5. Dibya Ranjan.B (10211) 6. Reena Julie (10212) Vignana Jyothi Institute of Management m
    Premium 6011 Words 25 Pages
  • Fdi Pharma Sectet
    ECONOMY OF INDIA The economy of India is the twelfth largest economy in the world by nominal value and the fourth largest by purchasing power parity (PPP). In the 1990s, following economic reform from the socialist-inspired economy of post-independence India, the country began to experien
    Premium 8385 Words 34 Pages
  • Pharma Analysis Article
    Analysis of the Indian Pharmaceutical Industry With Emphasis on Opportunities in 2005 Hemant N. Joshi The Indian Pharmaceutical Industry is expected to undergo phenomenal change after 1 January 2005, when international patent laws will be implemented. India’s domestic pharmaceutical companies
    Premium 9657 Words 39 Pages
  • Pharma Sector
    For a clearer market perspective The Top 10 Pharma Companies in India Growth strategies, performance and SWOT analyses Report Price Publication date £1995/ 2880/$3835 July 2009 H E A L T H C A R E The Top 10 Pharmaceutical Companies in India Growth strategies, performance and SWOT
    Premium 3223 Words 13 Pages
  • Pharma Biotech Marketing Problem
    Pharma-Biotech Marketing Problem Abstract: Pharmaceutical and Biotech companies have to market their products first to the doctors who then prescribe it to the patients, who are the final consumers. It is a big marketing hurdle with little or no differentiation in the drugs which are marketed to
    Premium 8943 Words 36 Pages
  • Indian Pharma Industry
    Pharmaceuticals in India : The Indian pharmaceutical industry is the world's second-largest by volume and is likely to lead the manufacturing sector of India. India's bio-tech industry clocked a 17 percent growth with revenues of Rs.137 billion ($3 billion) in the 2009-10 financial year over the
    Premium 4224 Words 17 Pages
  • Teva Pharma
    Teva Pharmaceutical Industries, Ltd 9 - 7 0 7 - 4 4 1 R E V : S E P T E M B E R 1 9 , 2 0 0 7 In Israel we have a 1970s song based on a poem from 1953 by Amir Gilboa about Theodor Herzl [the most important early advocate for the establishment of Israel]. It has a line in it ab
    Premium 10051 Words 41 Pages
  • A Study of the Role of Government of India in Helping Indian Pharma Industry Cope Up with the Challenges of Product Patent Regime
    European Journal of Economics, Finance and Administrative Sciences ISSN 1450-2275 Issue 13 (2008) © EuroJournals, Inc. 2008 http://www.eurojournalsn.com A Study of the Role of Government of India in Helping Indian Pharma Industry Cope up with the Challenges of Product Patent Regime Neeraj Dixit
    Premium 5587 Words 23 Pages
  • The Merger of Ranbaxy and Daiichi
    A REPORT ON Ranbaxy-Daiichi Deal 1/26/2012 Ranbaxy-Daiichi Deal Introduction: Daiichi Sankyo bought Ranbaxy for $4.6 billion in June 2008. This report studies the implications of the merger between Ranbaxy and Daiichi Sankyo, from an intellectual property as well as a market point of view.
    Premium 1123 Words 5 Pages
  • Ranbaxy
    Ranbaxy is one of the leading pharmaceutical Companies in India commanding a market share of around 5%. The Company has clocked sales of USD 293 Mn in 2009 in India. Growing ahead of the market, the Company has enhanced its competitive position in the domestic market through its focused approach. Th
    Premium 4166 Words 17 Pages
  • Ranbaxy Merger with Daiichi
    …“—‹•‹–‹‘ ‘ˆ ƒ„ƒš› „› ƒ‹‹…Š‹ ƒ›‘ A Project Report for the partial fulfillment of the PGDF Course at SYMBIOSIS CENTRE OF MANAGEMENT and HUMAN RESOURCE DEVELOPMENT Submitted by Jayant Agarwal (PGDF-02) …“—‹•‹–‹‘ ‘ˆ ƒ„ƒš› „› ƒ‹‹…
    Premium 5422 Words 22 Pages
  • Mergers & Acquisitions in Pharma Industry
    PROJECT REPORT ON A Successful International Merger in India: GlaxoSmithKline pharmaceutical industry
    Premium 21441 Words 86 Pages
  • Analysis of Pharma Sector in India
    Analysis of Indian Pharmaceutical Industry Dr. Reddy Laboratories Table of Contents Acknowledgement 4 1. Industry Analysis 5 1.1 Porter’s Five Forces Analysis 5 2. DRL’s Present Strategy 6 2.1Riding on Generics 6 2.2Focusing on depth rather than breadth 7 2.3 Leveraging strat
    Premium 6050 Words 25 Pages
  • Pharma in India
    The Pharmaceutical industry in India is the world's third-largest in terms of volume and stands 14th in terms of value.[1] According to Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the total turnover of India's pharmaceuticals industry between 2008 and September 2009 was US$
    Premium 2666 Words 11 Pages
  • Indian Pharma
    No. 2007-05-A OFFICE OF ECONOMICS WORKING PAPER U.S. INTERNATIONAL TRADE COMMISSION The Emergence of India’s Pharmaceutical Industry and Implications for the U.S. Generic Drug Market William Greene U.S. International Trade Commission May 2007 The author is with the Office of Economics
    Premium 17675 Words 71 Pages
  • Pharma Industry
    INDIAN PHARMACEUTICAL SECTOR Growth drivers strengthen in the near term; Patent expiries in the U.S. & Europe and domestic market are key ICRA RATING FEATURE Industry Update March 2012 Summary   After a brief period of sluggishness, the growth momentum in the domestic formulations market
    Premium 32615 Words 131 Pages